Detalhe da pesquisa
1.
Treatment of patients with Waldenström macroglobulinaemia: clinical practice update from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
Intern Med J
; 53(4): 599-609, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441109
2.
The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia.
Intern Med J
; 53(5): 819-824, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36880355
3.
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma Australia.
Intern Med J
; 51(10): 1707-1712, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664367
4.
Bisphosphonate guidelines for treatment and prevention of myeloma bone disease.
Intern Med J
; 47(8): 938-951, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28782211
5.
The use of cell free DNA (cfDNA) for mutational screening of multiple myeloma.
Leuk Res Rep
; 20: 100393, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37908506
6.
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1.
Haematologica
; 97(1): 64-72, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21993678
7.
The Role of Chaperone-Mediated Autophagy in Bortezomib Resistant Multiple Myeloma.
Cells
; 10(12)2021 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34943972
8.
Endoplasmic reticulum stress in the development of multiple myeloma and drug resistance.
Clin Transl Immunology
; 7(1): e1007, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29484184
9.
Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA.
Blood Cancer J
; 13(1): 113, 2023 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37495597
10.
Molecular mechanisms in multiple myeloma drug resistance.
J Clin Pathol
; 69(2): 97-101, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26598624
11.
Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres.
Bone Marrow Transplant
; 56(3): 738-740, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077903
12.
Comparing the area under the curve and peak height methods in the calculation of FLT3-ITD allelic ratio.
Int J Lab Hematol
; 42(5): e234-e236, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32533751
13.
The prognostic value of mid- and post-treatment [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma.
Ann Nucl Med
; 28(8): 805-11, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25008291
14.
Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation?
Am J Hematol
; 81(2): 110-4, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16432856